Showing 1911-1920 of 2494 results for "".
- Sydnexis Appoints Nick Ruth Chief as Commercial Officerhttps://modernod.com/news/sydnexis-appoints-nick-ruth-chief-as-commercial-officer/2481799/Sydnexis has announced the appointment of industry veteran Nick Ruth, MBA, as its Chief Commercial Officer (COO). Mr. Ruth will lead Sydnexis’ commercial strategy and transition from a clinical based organization to both a clinical and commercial based organization. With
- iOR Publishes Ophthalmic Office-Based Surgery Safety Studyhttps://modernod.com/news/ior-publishes-ophthalmic-office-based-surgery-safety-study/2481693/Office-based lens surgery can be performed safely, with adverse event rates similar to or lower than those in the published literature, according to a study published by iOR Partner
- Sight Sciences Appoints Ali Bauerlein as Chief Financial Officerhttps://modernod.com/news/sight-sciences-appoints-ali-bauerlein-as-chief-financial-officer/2481509/Sight Sciences announced the appointment of Alison “Ali” Bauerlein as its Chief Financial Officer and Treasurer, effective April 3, 2023. “I am incredibly excited to have Ali join Sight Sciences as we scale our business and drive toward profitable growth
- Staar Surgical Names Warren Foust Chief Operating Officer; Magda Michna, PhD, Chief Clinical, Regulatory and Medical Affairs Officerhttps://modernod.com/news/staar-surgical-names-warren-foust-chief-operating-officer-magda-michna-phd-chief-clinical-regulatory-and-medical-affairs-officer/2481498/Staar Surgical announced that Warren Foust has been named Chief Operating Officer, and Magda Michna, PhD, has been named Chief Clinical, Regulatory and Medical Affairs Officer. Both positions will report to Staar Surgical’s President and CEO, Tom Frinzi. “The addition of two
- Viridian Appoints Scott Myers as President and Chief Executive Officerhttps://modernod.com/news/viridian-appoints-scott-myers-as-president-and-chief-executive-officer/2481388/Viridian Therapeutics has appointed Scott Myers as President and Chief Executive Officer, as well as a member of the Board of Directors, effective February 6, 2023. He succeeds Jonathan Violin, PhD, who has led Viridian since its inception in 2020. “Our progres
- Neurotech Pharmaceuticals Appoints Scott Hunter as Chief Commercial Officerhttps://modernod.com/news/neurotech-pharmaceuticals-appoints-scott-hunter-as-chief-commercial-officer/2481341/Neurotech Pharmaceuticals announced the expansion of its executive team with the appointment of Scott Hunter as Chief Commercial Officer bringing two decades of eye care experience across both rare disease and specialty markets. “Scott’s appointment as the company&rsquo
- Alimera Sciences Appoints Industry Veteran Russell L. Skibsted as Chief Financial Officerhttps://modernod.com/news/alimera-sciences-appoints-industry-veteran-russell-l-skibsted-as-chief-financial-officer/2481331/Alimera Sciences announced the appointment of Russell L. Skibsted as Senior Vice President and Chief Financial Officer (CFO), effective January 9, 2023. “We are extremely excited to have someone of Russell’s caliber join us here at Alimera,” Rick Eiswirth, P
- Harrow Announces Availability of Fortisite Formulations for In-Office Usehttps://modernod.com/news/harrow-announces-availability-of-fortisite-formulations-for-in-office-use/2481322/Harrow announced the availability, for in-office use, of Fortisite (compounded Tobramycin 1.5% + Vancomycin 5%) from its FDA‑registered and FDA‑inspected ImprimisRx 503B outsourcing facility. Fortisite formulations are patent-pending high-concentration, refrigeration-stable, f
- Apellis Appoints Caroline Baumal, MD, as Chief Medical Officerhttps://modernod.com/news/apellis-appoints-caroline-baumal-md-as-chief-medical-officer/2481321/Apellis Pharmaceuticals announced that retina specialist Caroline Baumal, MD, has joined Apellis as chief medical officer. Dr. Baumal replaces Federico Grossi, MD, PhD, who plans to remain at Apellis until February 28, 2023 to help with the transition and preparations for the potential launc
- EyePoint Pharmaceuticals Promotes Jay S. Duker, MD, to President and Chief Operating Officerhttps://modernod.com/news/eyepoint-pharmaceuticals-promotes-jay-s-duker-md-to-president-and-chief-operating-officer/2481320/EyePoint Pharmaceuticals announced that Jay S. Duker, MD, who has served as the company’s Chief Operating Officer (COO) since November 2021, has been promoted to the additional role of President. In addition to continuing to oversee his duties as COO, in his expanded role, Dr. Duker wi